CVS Health Corporation
NYSE:CVSMedical - Healthcare Plans
Healthcare
$80.84 -0.59%
-$0.59 today
- Market cap
- $103.43B
- Beta
- 0.62
- P/E (TTM)
- 42.8
- EPS (TTM)
- $2.30
- Dividend yield
- 2.70%
52W Low $58.50High $102.77
Volume 10.71M
Average 8.19M
Income Statement
Follow revenue through to earnings.
Revenue
$402.07B
FY 2025 · Annual
+7.8% YoYOperating Income
$10.38B
FY 2025 · Annual
+21.9% YoYNet Income
$1.77B
FY 2025 · Annual
-61.7% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 292.11B | 322.47B | 357.78B | 372.81B | 402.07B |
| Cost of Revenue | 239.99B | 267.97B | 303.35B | 321.41B | 346.71B |
| Gross Profit | 52.12B | 54.5B | 54.43B | 51.4B | 55.36B |
| Gross Margin | 17.8% | 16.9% | 15.2% | 13.8% | 13.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 41.23B | 0 |
| Operating Expenses | 38.81B | 46.55B | 40.69B | 42.89B | 44.98B |
| Depreciation & Amortization | 4.49B | 4.22B | 4.37B | 4.6B | 4.61B |
| EBITDA | 17.53B | 12.35B | 18.2B | 13.68B | 9.86B |
| EBITDA Margin | 6.0% | 3.8% | 5.1% | 3.7% | 2.5% |
| Operating Income | 13.31B | 7.95B | 13.74B | 8.52B | 10.39B |
| Operating Margin | 4.6% | 2.5% | 3.8% | 2.3% | 2.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.5B | 2.29B | 2.66B | 2.96B | 3.12B |
| Other Income / Expenses | (2.77B) | (2.12B) | (2.57B) | (2.37B) | (8.25B) |
| Income Before Tax | 10.54B | 5.84B | 11.17B | 6.15B | 2.14B |
| Pre-Tax Margin | 3.6% | 1.8% | 3.1% | 1.6% | 0.5% |
| Income Tax Expense | 2.55B | 1.51B | 2.81B | 1.56B | 408M |
| Net Income | 8B | 4.31B | 8.34B | 4.61B | 1.77B |
| Net Margin | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% |
| EPS (Basic) | 6.00 | 3.29 | 6.49 | 3.66 | 1.40 |
| EPS (Diluted) | 5.95 | 3.26 | 6.47 | 3.66 | 1.39 |
| 1.32B | 1.31B | 1.29B | 1.26B | 1.27B | |
| 1.33B | 1.32B | 1.29B | 1.26B | 1.27B |
CVS Earnings Waterfall · TTM
NYSE:CVS · Revenue to Net Income
Key Ratios
EPS$3.78
Gross Margin14.2%
Net Margin1.2%
P/E Ratio5.4
P/S Ratio1.0
Analysis
$415.1B of revenue converted into $4.9B of net income for the selected period. Gross margin is 14.2% and net margin is 1.2%, showing how much revenue survives after costs and taxes. EPS is $3.78, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 13F-HR | 13F-HR filing | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 |
How much revenue does CVS generate?
CVS Health Corporation (CVS) reported $402.07B of revenue in fiscal 2025.
Is CVS profitable?
CVS Health Corporation (CVS) reported $1.77B of net income, with a net margin of 0.4%.
Continue the stock analysis
Jump to another research area for this company.